Birgitte Gangmark Villmo

Birgitte Gangmark Villmo serves as Investment Director and has held various investment roles at Investinor since October 2017, progressing from Investment Analyst to Senior Associate. Currently, Birgitte acts as a Board Member for APIM Therapeutics and Tellu AS, and as a Board Observer for Pluvia Biotech AS, with previous board memberships at Arxx Therapeutics and Hubro Therapeutics AS. Birgitte's prior experience includes roles as an Analyst at Norges Bank Investment Management and UBS Investment Bank. Educational qualifications include a Master of Finance from MIT Sloan School of Management and M.Sc. and BA degrees from the Norwegian University of Science and Technology.